ATE307634T1 - Photopherese-behandlung von hcv-infektionen - Google Patents

Photopherese-behandlung von hcv-infektionen

Info

Publication number
ATE307634T1
ATE307634T1 AT97916965T AT97916965T ATE307634T1 AT E307634 T1 ATE307634 T1 AT E307634T1 AT 97916965 T AT97916965 T AT 97916965T AT 97916965 T AT97916965 T AT 97916965T AT E307634 T1 ATE307634 T1 AT E307634T1
Authority
AT
Austria
Prior art keywords
patient
hcv infections
treatment
photopheresis treatment
blood
Prior art date
Application number
AT97916965T
Other languages
English (en)
Inventor
Susan N Mclaughlin
Bruce C Stouch
Christopher B O'brien
Original Assignee
Therakos Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Therakos Inc filed Critical Therakos Inc
Application granted granted Critical
Publication of ATE307634T1 publication Critical patent/ATE307634T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3681—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3681—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation
    • A61M1/3683—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation using photoactive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • External Artificial Organs (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AT97916965T 1996-03-29 1997-03-26 Photopherese-behandlung von hcv-infektionen ATE307634T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1461296P 1996-03-29 1996-03-29
PCT/US1997/004771 WO1997036634A1 (en) 1996-03-29 1997-03-26 Photopheresis treatment of chronic hcv infections

Publications (1)

Publication Number Publication Date
ATE307634T1 true ATE307634T1 (de) 2005-11-15

Family

ID=21766536

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97916965T ATE307634T1 (de) 1996-03-29 1997-03-26 Photopherese-behandlung von hcv-infektionen

Country Status (13)

Country Link
US (1) US20040062754A1 (de)
EP (1) EP0910428B1 (de)
JP (1) JP2000510003A (de)
CN (1) CN1214636A (de)
AT (1) ATE307634T1 (de)
AU (1) AU717624B2 (de)
BR (1) BR9708406A (de)
CA (1) CA2250920A1 (de)
DE (1) DE69734450T2 (de)
DK (1) DK0910428T3 (de)
ES (1) ES2251020T3 (de)
IL (1) IL126365A0 (de)
WO (1) WO1997036634A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0935462B1 (de) * 1996-03-29 2005-07-27 Therakos, Inc. Behandlung von leukocyten durch photopheresis
US7498156B2 (en) 1998-07-21 2009-03-03 Caridianbct Biotechnologies, Llc Use of visible light at wavelengths of 500 to 550 nm to reduce the number of pathogens in blood and blood components
US7049110B2 (en) 1998-07-21 2006-05-23 Gambro, Inc. Inactivation of West Nile virus and malaria using photosensitizers
US6219584B1 (en) 1999-07-09 2001-04-17 Therakos, Inc. Method and system for determining an effective amount of light energy to delivery to fluids having targets for the light energy
US7094378B1 (en) 2000-06-15 2006-08-22 Gambro, Inc. Method and apparatus for inactivation of biological contaminants using photosensitizers
US7220747B2 (en) 1999-07-20 2007-05-22 Gambro, Inc. Method for preventing damage to or rejuvenating a cellular blood component using mitochondrial enhancer
US6495366B1 (en) 1999-09-03 2002-12-17 Therakos, Inc. Uninterrupted flow pump apparatus and method
US9044523B2 (en) 2000-06-15 2015-06-02 Terumo Bct, Inc. Reduction of contaminants in blood and blood products using photosensitizers and peak wavelengths of light
JP2005517637A (ja) 2001-11-29 2005-06-16 セラコス・インコーポレイテッド 体外フォトフォレーシスおよび／またはアポプトーシス細胞による一定の被験体を前処理するための方法
US7211037B2 (en) 2002-03-04 2007-05-01 Therakos, Inc. Apparatus for the continuous separation of biological fluids into components and method of using same
US7479123B2 (en) 2002-03-04 2009-01-20 Therakos, Inc. Method for collecting a desired blood component and performing a photopheresis treatment
US20040127840A1 (en) 2002-03-04 2004-07-01 Steve Gara Blood separation apparatus and method of using the same
US7186230B2 (en) 2002-03-04 2007-03-06 Therakos, Inc Method and apparatus for the continuous separation of biological fluids into components
DE202004004263U1 (de) 2004-03-18 2004-05-19 Weber, Waldfried Bestrahlungsgerät für Blut
BR122018074426B8 (pt) 2005-11-02 2021-07-27 Therakos Inc método de geração de células t com atividade reguladora
EP2021493A4 (de) 2006-05-02 2010-04-14 Therakos Inc Verfahren und reagenzien für den nachweis von anfälligkeit für transplantat-gegen-empfänger-krankheit oder transplantatbedingte mortalität
ITVE20070005A1 (it) * 2007-01-25 2008-07-26 Associazione Veneta Per La Lotta Alla Talassemia Farmaco per la cura della talassemia, dell'anemia falciforme e di tutte le altre forme di anemia trattabili con questo, metodo di attivazione del farmaco, composizione farmaceutica avente come principio attivo il farmaco e metodo fotochemioterapico u
US10441810B2 (en) 2007-04-08 2019-10-15 Immunolight, Llc X-ray psoralen activated cancer therapy (X-PACT)
US9358292B2 (en) 2007-04-08 2016-06-07 Immunolight, Llc Methods and systems for treating cell proliferation disorders
US10596387B2 (en) * 2007-04-08 2020-03-24 Immunolight, Llc. Tumor imaging with X-rays and other high energy sources using as contrast agents photon-emitting phosphors having therapeutic properties
WO2017070197A1 (en) 2015-10-19 2017-04-27 Immunolight, Llc X-ray psoralen activated cancer therapy (x-pact)
WO2015164487A1 (en) * 2014-04-22 2015-10-29 Immunolight, Llc Interior energy-activation of photo-reactive species inside a medium or body using an x-ray source emitting low energy x-rays as initiation energy source
CA3178687A1 (en) * 2020-04-12 2021-10-21 Aethlon Medical, Inc. Devices and methods for treating a coronavirus infection and symptoms thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4321919A (en) * 1979-12-11 1982-03-30 Leukocyte Research, Inc. Method and system for externally treating human blood
US4727027A (en) * 1983-05-02 1988-02-23 Diamond Scientific Co. Photochemical decontamination treatment of whole blood or blood components
US4878891A (en) * 1987-06-25 1989-11-07 Baylor Research Foundation Method for eradicating infectious biological contaminants in body tissues
US5288605A (en) * 1992-03-02 1994-02-22 Steritech, Inc. Methods for inactivating bacteria in blood preparations with 8-methoxypsoralen
US5399719A (en) * 1993-06-28 1995-03-21 Steritech, Inc. Compounds for the photodecontamination of pathogens in blood
WO1997021346A1 (en) * 1995-12-14 1997-06-19 Cerus Corporation Inactivation of non-enveloped virus
EP0935462B1 (de) * 1996-03-29 2005-07-27 Therakos, Inc. Behandlung von leukocyten durch photopheresis
AU2453697A (en) * 1996-04-10 1997-10-29 Trustees Of The University Of Pennsylvania, The Use of photopheresis in the treatment of chronic infection by hepatitis c virus

Also Published As

Publication number Publication date
US20040062754A1 (en) 2004-04-01
JP2000510003A (ja) 2000-08-08
WO1997036634A1 (en) 1997-10-09
ES2251020T3 (es) 2006-04-16
DK0910428T3 (da) 2006-02-13
AU2544197A (en) 1997-10-22
BR9708406A (pt) 2000-01-04
CA2250920A1 (en) 1997-10-09
IL126365A0 (en) 1999-05-09
CN1214636A (zh) 1999-04-21
DE69734450D1 (de) 2005-12-01
EP0910428A4 (de) 2001-03-28
EP0910428B1 (de) 2005-10-26
AU717624B2 (en) 2000-03-30
EP0910428A1 (de) 1999-04-28
DE69734450T2 (de) 2006-08-10

Similar Documents

Publication Publication Date Title
DE69734450D1 (de) Photopherese-behandlung von hcv-infektionen
EP0935462A4 (de) Behandlung von leukocyten durch photopheresis
NZ309217A (en) Ribavirin and interferon alpha for the treatment of hepatitis C
GEP20002146B (en) Therapeutic Peptide Derivatives
DE69834724D1 (de) Behandlung von Darm- oder Blasenentzündungen
ATE199643T1 (de) Therapeutisches kombinationspräparat enthaltend interferon
ATE282425T1 (de) Verfahren zur behandlung von endothelialen verletzungen
ATE97813T1 (de) Mittel zur kontrolle von thrombenbildungen.
DK0741577T3 (da) Anvendelsen af enterferon, subtype alfa 8, til fremstilling af lægemidler til behandling af virusinfektioner i leveren
FI953565A7 (fi) Uusi antikoagulanttikofaktoriaktiivisuus
ATE228854T1 (de) Immunoglobuline der g-klasse zur lokalen behandlung von hautentzündungen
PT859630E (pt) Combinacao de temozolomida e alfa-ifn no tratamento de cancro avancado
RU98119730A (ru) Лечение с помощью фотофереза хронического гепатита с
RU92011195A (ru) Способ уменьшения дозы химиопрепаратов, используемых для лечения инфекционных заболеваний при одновременном повышении их терапевтической эффективности
UA28207A (uk) Спосіб лікування черепно-мозкової травми
RU92001489A (ru) Препарат для лечения инфекционного гепатита, способ получения препарата и способ лечения гепатита
UA33890A (uk) Спосіб лікування хвороби пейроні
MY109685A (en) Method for treating hepatitis b carriers with minimal disease
UA11276C2 (uk) Спосіб реабілітації хворих, які переhесли вірусhий гепатит
RU95108457A (ru) Способ лечения тяжелых форм глпс

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0910428

Country of ref document: EP